Your Location：
Home >
Browse articles >
Chinese Medicine Regulates NLRP3 Inflammasomes to Treat Diabetic Nephropathy： A Review
Chinese Medicine Regulates NLRP3 Inflammasomes to Treat Diabetic Nephropathy： A Review
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 23, Pages: 197-206(2023)
DOI： 10.13422/j.cnki.syfjx.20231495
Scan QR Code
Full Text(HTML)
Figs( 1 ) Tabs( 2 )
References
Publication Info
Metrics
297
Views
606
Downloads
5
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Chinese Medicine Regulating TGF-β1/Smad Signaling Pathway in Treatment of Diabetic Nephropathy： A Review
Mechanism of Huazhuo Jiedu Prescription in Alleviating Renal Fibrosis in 5/6 Nephrectomy Rats Based on AMPK/mTOR Pathway
Programmed Cell Death in Endometriosis and Traditional Chinese Medicine Intervention： A Review
Effect of Buyang Huanwutang in Treating Diabetic Peripheral Neuropathy by Inhibiting Pyroptosis Through AMPK/ULK1 Mitophagy Pathway
Staged Efficacy of Qijia Rougan Prescription Combined with Entecavir for Chronic Hepatitis B-related Hepatic Fibrosis with Qi Deficiency and Collateral Stasis Syndrome Based on "Zhu Ke Jiao" Theory
Related Author
PAN Baochao
LI Hanzhou
ZHANG Hui
LI Yimeng
WEN Weibo
LYU Shuquan
WANG Wanqing
WANG Yashi
Related Institution
Graduate School，Hebei University of Chinese Medicine
Chengde Medical University
Cangzhou Third Hospital
The First Affiliated Hospital of Yunnan University of Chinese Medicine
Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Hebei University of Chinese Medicine
Chat
